Global Erectile Dysfunction Drugs Market By Product Type (Branded Drugs (Viagra, Cialis, Zydena, and Others) and Generic Drugs (Sildenafil, Tadalafil, Vardenafil, Alprostadil, and Others)), By Route of Administration (Oral, Injectable, Topical and Intraurethral Suppositories), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 98373
- Number of Pages: 287
- Format:
-
keyboard_arrow_up
-
-
- Novartis AG Company Profile
- Eli Lilly and Company
- Pfizer Inc Company Profile
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma Limited
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.
- Accord Healthcare Inc.
- CURE Pharmaceutical
- Adamed
- Aspargo Laboratories, Inc.
- Dong-A Pharmaceutical Co., Ltd
- Other Key Players
- settingsSettings
Our Clients
- 98373
- March 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
